IDBS, a leading provider of cloud software for biopharma companies and a Danaher company, is proud to announce that it has been awarded the Best Biologics Digitalisation: Software Innovation Award, at the Asia Pacific Biopharma Excellence Awards (ABEA) 2026. This prestigious recognition highlights IDBS’ outstanding contributions to enabling digital transformation and advancing biopharma excellence in the Asia-Pacific region.
As part of the ABEA’s Biologics Digitalisation award categories, which recognize technologies transforming biologics development, the honor reflects the increasing focus on digital tools that enhance process efficiency, data quality and scientific advancement.
“This award is a tremendous honor for IDBS and a testament to the groundbreaking work our teams deliver globally,” said Pietro Forgione, General Manager at IDBS. “Biologics development is evolving rapidly, and our mission is to help organizations simplify complexity, accelerate scientific outcomes, and ensure the highest standards of quality and data integrity. Recognition from the biopharma community in the Asia‑Pacific region reinforces the value our technology delivers to biopharma organizations worldwide.”
The awards ceremony took place on March 11th at the Sands Expo & Convention Centre, Singapore, alongside IMAPAC’s Biologics World Asia conference, which attracts around 1,300 industry leaders from across the region.
Read Also: A Satellite Connectivity Milestone: MTN Launches New Click-to-Deploy Satellite Service on AWS
